BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 18408076)

  • 21. Impact of uraemia on food efficiency and the pulsatile mode of growth hormone secretion in rats.
    Krieg RJ; Latta K; Niimi K; Veldhuis JD; Chan JC
    J Endocrinol; 1995 Sep; 146(3):509-17. PubMed ID: 7595147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth impairment of primary chondrocyte cells by serum of rats with chronic renal failure.
    Mak RH; Chang SL; Pak YK
    Exp Mol Med; 2004 Jun; 36(3):243-50. PubMed ID: 15272236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous enteral feeding in uremic rats.
    Maniar S; Laouari D; Motel V; Kleinknecht C
    Miner Electrolyte Metab; 1996; 22(1-3):88-91. PubMed ID: 8676834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of parathyroid gland hyperplasia without uremia: role of dietary calcium and phosphate.
    Canalejo A; Canalejo R; Rodriguez ME; Martinez-Moreno JM; Felsenfeld AJ; Rodríguez M; Almaden Y
    Nephrol Dial Transplant; 2010 Apr; 25(4):1087-97. PubMed ID: 19934096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nitrogen metabolism and growth in experimental uremia.
    Mehls O; Ritz E; Gilli G; Bartholomé K; Beissbarth H; Hohenegger M; Schafnitzel W
    Int J Pediatr Nephrol; 1980 Mar; 1(1):34-41. PubMed ID: 7343527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia.
    Amann K; Törnig J; Kugel B; Gross ML; Tyralla K; El-Shakmak A; Szabo A; Ritz E
    Kidney Int; 2003 Apr; 63(4):1296-301. PubMed ID: 12631346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of acute 5-fluorouracil chemotherapy and insulin-like growth factor-I pretreatment on growth plate cartilage and metaphyseal bone in rats.
    Xian CJ; Howarth GS; Cool JC; Foster BK
    Bone; 2004 Sep; 35(3):739-49. PubMed ID: 15336611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1-34) on chondrogenesis in a model of experimental fracture healing.
    Nakazawa T; Nakajima A; Shiomi K; Moriya H; Einhorn TA; Yamazaki M
    Bone; 2005 Nov; 37(5):711-9. PubMed ID: 16143574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human PTH (1-34) induces longitudinal bone growth in rats.
    Ogawa T; Yamagiwa H; Hayami T; Liu Z; Huang KY; Tokunaga K; Murai T; Endo N
    J Bone Miner Metab; 2002; 20(2):83-90. PubMed ID: 11862529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low zinc intake suppressed N-methyl-N-nitrosourea-induced mammary tumorigenesis in Sprague-Dawley rats.
    Lee S; Simpson M; Nimmo M; Xu Z
    Carcinogenesis; 2004 Oct; 25(10):1879-85. PubMed ID: 15205360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations in the growth plate cartilage of rats with renal failure receiving corticosteroid therapy.
    Sanchez CP; He YZ
    Bone; 2002 May; 30(5):692-8. PubMed ID: 11996906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adaptation of mechanical, morphological, and biochemical properties of the rat growth plate to dose-dependent voluntary exercise.
    Niehoff A; Kersting UG; Zaucke F; Morlock MM; Brüggemann GP
    Bone; 2004 Oct; 35(4):899-908. PubMed ID: 15454097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Daily or intermittent calcitriol administration during growth hormone therapy in rats with renal failure and advanced secondary hyperparathyroidism.
    Sanchez CP; He YZ
    J Am Soc Nephrol; 2005 Apr; 16(4):929-38. PubMed ID: 15728789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cinacalcet HCl suppresses Cyclin D1 oncogene-derived parathyroid cell proliferation in a murine model for primary hyperparathyroidism.
    Imanishi Y; Kawata T; Kenko T; Wada M; Nagano N; Miki T; Arnold A; Inaba M
    Calcif Tissue Int; 2011 Jul; 89(1):29-35. PubMed ID: 21541686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute blood pressure effects and chronic hypotensive action of calcimimetics in uremic rats.
    Odenwald T; Nakagawa K; Hadtstein C; Roesch F; Gohlke P; Ritz E; Schaefer F; Schmitt CP
    J Am Soc Nephrol; 2006 Mar; 17(3):655-62. PubMed ID: 16421225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement of growth and food utilization by human recombinant growth hormone in uremia.
    Mehls O; Ritz E; Hunziker EB; Eggli P; Heinrich U; Zapf J
    Kidney Int; 1988 Jan; 33(1):45-52. PubMed ID: 3352160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapamycin retards growth and causes marked alterations in the growth plate of young rats.
    Alvarez-Garcia O; Carbajo-Pérez E; Garcia E; Gil H; Molinos I; Rodriguez J; Ordoñez FA; Santos F
    Pediatr Nephrol; 2007 Jul; 22(7):954-61. PubMed ID: 17370095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Daily but not pulse calcitriol therapy improves growth in experimental uremia.
    Mehls O; Knöller N; Oh J; Wesch H; Wünsche B; Schmitt CP
    Pediatr Nephrol; 2000 Jul; 14(7):658-63. PubMed ID: 10912538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of growth hormone treatment on growth plate, bone, and mineral metabolism of young rats with uremia induced by adenine.
    Claramunt D; Gil-Peña H; Fuente R; García-López E; Hernández Frías O; Ordoñez FA; Rodríguez-Suárez J; Santos F
    Pediatr Res; 2017 Jul; 82(1):148-154. PubMed ID: 28376076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced physeal area and chondrocyte proliferation in Pasteurella multocida toxin-treated rats.
    Ackermann MR; Stabel JR; Pettit RK; Jacobson CD; Elmquist JK; Register KB; Rimler RB; Hilton JH
    Vet Pathol; 1995 Nov; 32(6):674-82. PubMed ID: 8592803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.